We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
The Therapeutic Goods Administration (TGA) wishes to notify consumers that Apotex Pty Ltd is undertaking an urgent consumer level recall of specified batches of APO-Perindopril 2mg tablets in blister packs of 30 tablets.
This action is being taken because some cartons of APO-Perindopril 2mg tablets may contain 8mg tablets.
How to identify the products being recalled
APO-Perindopril 2mg tablets cartons marked with the following batch numbers are affected:
| Batch number | Expiry date |
|---|---|
| 24967 | April 2013 |
| 24979 | April 2013 |
| 25180 | May 2013 |
| 25184 | May 2013 |
The batch numbers are displayed on the end flap of the 2mg carton.
About the medicine
Perindopril is a medicine used to treat high blood pressure and heart failure. A patient taking an 8mg tablet instead of a 2 mg tablet could suffer serious adverse effects such as low blood pressure, dizziness and fainting.
To date no adverse events have been reported to the TGA in relation this product.
What consumers and patients should do
If you have APO-Perindopril 2mg tablets from one of the above batches in your possession you should return these to your pharmacy as quickly as possible to arrange for a replacement.
If you have concerns about the use of this product you should consult your medical practitioner.